葡萄中分离的化合物可作为治疗抑郁症的药物

In a study to be published online February 2 in Nature Communications, scientists from the Icahn School of Medicine at Mount Sinai describe an extensive analysis of novel grape-derived compounds, dihydrocaffeic acid (DHCA) and malvidin-3'-O-glucoside (Mal-gluc),which might be developed as therapeutic agents for the treatment of depression.

见：

Novel grape-derived compounds could be developed as therapeutic agents for treatment of depression